CRWD

Axon’s run: What should readers do now? It has been little more than a year since I first recommended Axon (AXON) shares. So far in 2024, the shares are up 68% and they have consistently been making new all-time highs. The quintessential pattern of a momentum growth stock. Much of the share price increase has come since the latest earnings…

To access this post, you must subscribe.

Read More

Summary Zscaler and Crowdstrike are leaders in two different segments of the cyber security space. Both companies have achieved rapid growth, with the advantage slightly to Crowdstrike recently. Both companies are achieving significant free cash flow margins. Zscaler shares have seen a material valuation compression, both on a relative and absolute basis. At this point…

To access this post, you must subscribe.

Read More

The divergence between Crowdstrike and Zscaler (and most everything else). The misunderstood quarter of GitLab; Pagaya raises EBITDA guidance-hopefully construed positively. 1. Crowdstrike Pattern recognition is supposed to be the mainstay of analysis. Most of the time, when I attempt to write an article about a company, or an event, I try to compare it…

To access this post, you must subscribe.

Read More

Portfolio Change

Sale of remaining position in Crowdstrike; Purchase of additional shares of SentinelOne Shares of SentinelOne are under extraordinary pressure this morning. A minor guidedown in revenue of less than 0.5% has led to an extraordinary valuation implosion. I usually wait these things out, but a limit order I had was filled. After yesterday’s precipitous fall,…

To access this post, you must subscribe.

Read More

Sale of 100 shares of Crowdstrike at the opening; Sale of 100 shares of DT at the opening; Purchase of 120 shares of CyberArk at the opening, Purchase of 40 shares of Datadog; Comments on the ZS downgrades As we discussed in the portfolio commentary we published yesterday, we are exiting our Crowdstrike position. The…

To access this post, you must subscribe.

Read More

Sale of 50 shares of Crowdstrike; Purchase of 80 shares of CyberArk Very reluctantly, we decided to sell 25% of our Crowdstrike position today. Our sale price was $348.49 and the sale raided about $17,415. Crowdstrike shares have risen by more than 18% in the last 3+ weeks. That kind of performance is far greater…

To access this post, you must subscribe.

Read More

The last few weeks have not been fun times for investors in the cybersecurity space. Subsequent to Palo Alto’s earning report and guidedown, the cyber security space has seen an ugly trading pattern. That ugly pattern was reinforced by the recent results of Zscaler, despite a rather irrational take on that earnings report. And then…

To access this post, you must subscribe.

Read More

Sale of 200 shares of Crowdstrike and 250 shares of Monday.com-entire position. Purchase of 400 shares of CFLT; 300 shares of PCOR; 200 shares of AFRM; 600 shares of SentinelOne; and 200 shares of GLBE I started 2024 thinking there would be a few weeks of consolidation after the strong run at the end of 2023. The…

To access this post, you must subscribe.

Read More

Crowdstrike, like Zscaler is one of the cornerstones of any high growth IT portfolio. I am not going to reprise all the metrics that were reported last evening. There were no disappointments. Most impressive, at least to me, was the growth in net new ARR which was $223 million, and was up by 13%. Remember,…

To access this post, you must subscribe.

Read More

Pure and Crowdstrike are the #1 and #2 holdings in our high growth model portfolio. The two companies together account for more than 20% of the value in the portfolio. So it makes sense, I think, to review their earnings sooner rather than wait until the weekly commentary is published. While neither company reported what…

To access this post, you must subscribe.

Read More